Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Cesarone

Showing results (41-50 of 226) with videos related to

Pageof 23
Sort By:
Minerva Cardioangiologica|December 1, 1991
[Efficacy of TTFCA in reducing the ratio between lymphatic and plasma protein concentration in lymphatic and postphlebitic edema]M R Cesarone, G Laurora, P Pomante, et al.
The Journal of Cardiovascular Surgery|August 1, 1993
Delayed arteriosclerosis progression in high risk subjects treated with mesoglycan. Evaluation of intima-media thicknessG Laurora, M R Cesarone, M T De Sanctis, et al.
Minerva Cardioangiologica|February 5, 2000
[Reduction of cardiovascular morbidity/mortality in arteriopathies treated ith PGE1 alpha-cyclodextrin]G Belcaro, M Bucci, M R Cesarone, et al.
Angiology|January 5, 2002
Treatment of superficial vein thrombophlebitis of the arm with Essaven gel--a placebo-controlled, randomized studyM T De Sanctis, M R Cesarone, L Incandela, et al.
Panminerva Medica|March 1, 1993
Skin flux and the venoarteriolar response in essential hypertensionM R Cesarone, G Laurora, M T De Sanctis, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|May 16, 2002
Treatment of diabetic microangiopathy and edema with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): a prospective, placebo-controlled, randomized studyL Incandela, M R Cesarone, M T DeSanctis, et al.
Minerva Cardioangiologica|August 6, 2003
[Treatment of a femoral venous aneurysm with foam-sclerotherapy]M R Cesarone, G Belcaro, A N Nicolaides, et al.
Current Medical Research and Opinion|May 2, 2001
Microcirculatory studies in erectile disordersG Belcaro, M R Cesarone, A N Nicolaides, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|May 16, 2002
Variations in plasma free radicals in patients with venous hypertension with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): a clinical, prospective, placebo-controlled, randomized trialM R Cesarone, L Incandela, M T DeSanctis, et al.
Minerva Cardioangiologica|May 1, 1989
[Venoruton and capillary permeability]M R Cesarone, G Laurora, M Gabini, et al.
Pageof 23

Showing results (41-50 of 226) with videos related to

Sort By:
Pageof 23
Minerva Cardioangiologica|December 1, 1991
[Efficacy of TTFCA in reducing the ratio between lymphatic and plasma protein concentration in lymphatic and postphlebitic edema]M R Cesarone, G Laurora, P Pomante, et al.
The Journal of Cardiovascular Surgery|August 1, 1993
Delayed arteriosclerosis progression in high risk subjects treated with mesoglycan. Evaluation of intima-media thicknessG Laurora, M R Cesarone, M T De Sanctis, et al.
Minerva Cardioangiologica|February 5, 2000
[Reduction of cardiovascular morbidity/mortality in arteriopathies treated ith PGE1 alpha-cyclodextrin]G Belcaro, M Bucci, M R Cesarone, et al.
Angiology|January 5, 2002
Treatment of superficial vein thrombophlebitis of the arm with Essaven gel--a placebo-controlled, randomized studyM T De Sanctis, M R Cesarone, L Incandela, et al.
Panminerva Medica|March 1, 1993
Skin flux and the venoarteriolar response in essential hypertensionM R Cesarone, G Laurora, M T De Sanctis, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|May 16, 2002
Treatment of diabetic microangiopathy and edema with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): a prospective, placebo-controlled, randomized studyL Incandela, M R Cesarone, M T DeSanctis, et al.
Minerva Cardioangiologica|August 6, 2003
[Treatment of a femoral venous aneurysm with foam-sclerotherapy]M R Cesarone, G Belcaro, A N Nicolaides, et al.
Current Medical Research and Opinion|May 2, 2001
Microcirculatory studies in erectile disordersG Belcaro, M R Cesarone, A N Nicolaides, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|May 16, 2002
Variations in plasma free radicals in patients with venous hypertension with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): a clinical, prospective, placebo-controlled, randomized trialM R Cesarone, L Incandela, M T DeSanctis, et al.
Minerva Cardioangiologica|May 1, 1989
[Venoruton and capillary permeability]M R Cesarone, G Laurora, M Gabini, et al.
Pageof 23